BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 18712055)

  • 1. Cholesterol reduction and atherosclerosis inhibition by bezafibrate in low-density lipoprotein receptor knockout mice.
    Inaba T; Yagyu H; Itabashi N; Tazoe F; Fujita N; Nagashima S; Okada K; Okazaki M; Furukawa Y; Ishibashi S
    Hypertens Res; 2008 May; 31(5):999-1005. PubMed ID: 18712055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid cell-specific ATP-binding cassette transporter A1 deletion has minimal impact on atherogenesis in atherogenic diet-fed low-density lipoprotein receptor knockout mice.
    Bi X; Zhu X; Gao C; Shewale S; Cao Q; Liu M; Boudyguina E; Gebre AK; Wilson MD; Brown AL; Parks JS
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1888-99. PubMed ID: 24833800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.
    Park JG; Xu X; Cho S; Lee AH
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1772-81. PubMed ID: 27417587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan Oligosaccharides Attenuate Atherosclerosis and Decrease Non-HDL in ApoE-/- Mice.
    Yu Y; Luo T; Liu S; Song G; Han J; Wang Y; Yao S; Feng L; Qin S
    J Atheroscler Thromb; 2015; 22(9):926-41. PubMed ID: 25843117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis.
    Hsieh J; Koseki M; Molusky MM; Yakushiji E; Ichi I; Westerterp M; Iqbal J; Chan RB; Abramowicz S; Tascau L; Takiguchi S; Yamashita S; Welch CL; Di Paolo G; Hussain MM; Lefkowitch JH; Rader DJ; Tall AR
    Nature; 2016 Jul; 535(7611):303-7. PubMed ID: 27383786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis.
    Joyce CW; Wagner EM; Basso F; Amar MJ; Freeman LA; Shamburek RD; Knapper CL; Syed J; Wu J; Vaisman BL; Fruchart-Najib J; Billings EM; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB
    J Biol Chem; 2006 Nov; 281(44):33053-65. PubMed ID: 16928680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in dietary omega-6 polyunsaturated fatty acids: eicosapentaenoic acid plus docosahexaenoic acid ratio minimizes atherosclerotic lesion formation and inflammatory response in the LDL receptor null mouse.
    Wang S; Wu D; Matthan NR; Lamon-Fava S; Lecker JL; Lichtenstein AH
    Atherosclerosis; 2009 May; 204(1):147-55. PubMed ID: 18842266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of probucol and benzafibrate on lipoprotein metabolism and liver cholesteryl ester transfer protein mRNA in cholesterol-fed rabbits.
    Ou J; Saku K; Jimi S; Liao YL; Ohta T; Zhang B; Arakawa K
    Jpn Circ J; 1999 Jun; 63(6):471-7. PubMed ID: 10406588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aortic cholesterol accumulation correlates with systemic inflammation but not hepatic and gonadal adipose tissue inflammation in low-density lipoprotein receptor null mice.
    Wang S; Miller B; Matthan NR; Goktas Z; Wu D; Reed DB; Yin X; Grammas P; Moustaid-Moussa N; Shen CL; Lichtenstein AH
    Nutr Res; 2013 Dec; 33(12):1072-82. PubMed ID: 24267047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.
    Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2288-96. PubMed ID: 23814116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice.
    Song G; Tian H; Qin S; Sun X; Yao S; Zong C; Luo Y; Liu J; Yu Y; Sang H; Wang X
    Atherosclerosis; 2012 Mar; 221(1):55-65. PubMed ID: 22209213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced ABCG1 expression increases atherosclerosis in LDLr-KO mice on a western diet.
    Basso F; Amar MJ; Wagner EM; Vaisman B; Paigen B; Santamarina-Fojo S; Remaley AT
    Biochem Biophys Res Commun; 2006 Dec; 351(2):398-404. PubMed ID: 17070501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
    Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
    FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ces3/TGH deficiency improves dyslipidemia and reduces atherosclerosis in Ldlr(-/-) mice.
    Lian J; Quiroga AD; Li L; Lehner R
    Circ Res; 2012 Sep; 111(8):982-90. PubMed ID: 22872154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism.
    Fruchart JC; Duriez P
    Drugs Today (Barc); 2006 Jan; 42(1):39-64. PubMed ID: 16511610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice.
    van der Sluis RJ; Nahon JE; Reuwer AQ; Van Eck M; Hoekstra M
    Br J Pharmacol; 2015 May; 172(9):2397-405. PubMed ID: 25572138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
    Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis.
    Ma L; Zhong J; Zhao Z; Luo Z; Ma S; Sun J; He H; Zhu T; Liu D; Zhu Z; Tepel M
    Cardiovasc Res; 2011 Dec; 92(3):504-13. PubMed ID: 21908651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.